Skip to main content
Clinical Trials/NL-OMON39657
NL-OMON39657
Completed
Not Applicable

Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON study - Haloperidol prophylaxis in older acutely admitted patients

Vrije Universiteit Medisch Centrum0 sites780 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
acute state of confusion
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
780
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients aged 70 years or over;
  • \- The patient is at increased risk for developing in\-hospital delirium on admission according to one or more positive answers on the VMS delirium\-risk questions;
  • \- The patient or proxy is able to provide written informed consent;
  • \- The patient or proxy speaks either Dutch or English;
  • \- The patient is admitted to the hospital for an internal or surgical specialty.

Exclusion Criteria

  • \- Patients presenting in the ED with delirium according to the DSM\-IV criteria;
  • \- Patients with clinically significant (cardiac) disorders: QTc interval prolongation (QTc \* 500ms), recent acute myocardial infarction, uncompensated heart failure (working diagnosis), acute coronary syndrome (ACS), arrhythmias treated with class IA and III antiarrhythmic medicinal products, history of ventricular arrhythmia, history of torsade de pointes, clinically significant bradycardia, second or third degree heart block, uncorrected hypokalaemia (potassium level 3\.0 or lower);
  • \- Patients with vascular dementia;
  • \- Patients with Lewy Body dementia;
  • \- Patients with Parkinson (dementia);
  • \- Patients with (a history of) hypokinetic movement disorders;
  • \- Patients with (a history of) malignant neuroleptic syndrome;
  • \- Patients with (a history of) serotonergic syndrome;
  • \- Patients with (a history of) central anticholinergic syndrome;
  • \- Patients who will be admitted to the oncology ward;

Outcomes

Primary Outcomes

Not specified

Similar Trials